Sign up for our free China-Africa Week in Review email newsletter
  • This field is for validation purposes and should be left unchanged.

Follow CAP on Social Media

Listen to the CAP Podcast

Why One Chinese COVID-19 Vaccine, in Particular, is Poised to Have a Huge Impact in the Developing World

Image of CanSino Biologics Inc. COVID019 vaccines that only require a single shot and less onerous cold chain requirements than other vaccines on the market. Image via CanSino.

A new Chinese-made vaccine emerged from late-stage clinical trials this week, well-positioned to help overcome a number of the obstacles that have hampered large-scale distribution of COVID-19 jabs to the world’s poorest countries, including many in Africa.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Connect with leading professionals on the China- Africa Experts Network.

You’ve reached your free monthly article limit.

Subscribe today for unlimited access.

What is The China-Africa Project?


The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.